Dr. Gray joined Ambry in 2007 and currently serves as Director of Assay Development. Dr. Gray began working with next generation sequencing technologies in 2007 and has expertise on several sequencing platforms and sample preparation/enrichment technologies. As an early user of these new genomics technologies, he brings a wealth of knowledge and experience to Ambry’s Research and Development team. Throughout his career, Dr. Gray has held positions at Invitrogen/Life Technologies, Booz Allen Hamilton, and Abbott Molecular. Dr. Gray received his undergraduate degree in Biology from Georgia State University and received his Ph.D. in Applied Biology from the Georgia Institute of Technology.